MedTrace Logo

Towards Optimal Screening and Management of Coronary Artery Disease in Diabetes: TOSCANA Study

NCT05314140 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2026-02-17

No results posted yet for this study

Summary

There are currently only few data on the coronary artery calcium score in patient with diabetes in France, and the diagnostic and therapeutic attitudes towards a high coronary artery calcium score are not standardized and depend on clinical practices, which may vary from one center to another. The proposed multicenter prospective study would provide a better understanding of the epidemiological particularities of the coronary artery calcium score in French diabetics, refine the indications for better performance of the examination, and compare attitudes when this score is high.

Conditions

Interventions

DIAGNOSTIC_TEST

Coronary artery calcium score evaluation

The evaluation of the coronary artery calcium score will be performed with chest CT scan

Sponsors & Collaborators

  • Novo Nordisk A/S

    collaborator INDUSTRY

  • CEBIMER

    collaborator UNKNOWN

  • French Cardiology Society

    lead OTHER

Principal Investigators

  • Victor ABOYANS, MD · University Hospital, Limoges

  • Tessa BERGOT · Société Française de la Cardiologie

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-31
Primary Completion
2028-01-01
Completion
2028-01-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05314140 on ClinicalTrials.gov